Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06632951 |
Title | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC) (LIVIGNO-3) |
Acronym | LIVIGNO-3 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | AbbVie |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ISR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Highlands Oncology Group - Springdale /ID# 270290 | RECRUITING | Springdale | Arkansas | 72762 | United States | Details |
Tel Aviv Sourasky Medical Center /ID# 270106 | RECRUITING | Tel Aviv | Tel-Aviv | 6423906 | Israel | Details |
Rabin Medical Center /ID# 270107 | RECRUITING | Haifa | 4941492 | Israel | Details |